Login

Transport Infrastructure Group Before Discussing R&D Site Strategic Factors in Magny-les-Hameaux | Frédéric Gardès - CEO of Colas Group 00:10:00

Share On Facebook Share On Twitter

Frédéric Gardès is the CEO of Colas Group

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Making the Transition to PDS Seamless and Stress-Free for Clients
00:10:00
Everest Wealth Management: Secure Your Retirement with Guaranteed Growth
00:10:00
Chip Hamiller: What Sets Beacon Financial Strategies Apart
00:00:00
Johannes Walter, Faculty at Harvard Medical School (HMS) | DNA Replication in Cancer Cell Biology
00:10:00
Denis Phares: Leading Dragonfly Energy to New Heights | Denis Phares - CEO of Dragonfly Energy Corporation
00:10:00
Lessons from Archegos: Octavio Marenz on Credit Suisse’s $4.7 Billion Loss | Octavio Marenz – Founder & CEO, Opimas
00:10:00
The Evolving Role of the Non-Executive Director in a Post-COVID World | Steven Fine, CEO, Peel Hunt Ltd.
00:10:00
Nickel Industry Faces Production Cuts and Environmental Challenges Amid Low Price
00:10:00
Richardson Electronics, Ltd. (NASDAQ: RELL) CEO Edward Richardson sat down with Proactive Investors at the 11th Annual LD Micro Main Event.
00:10:00
Silver Market Dynamics: Supply Growth, Geopolitical Impacts, and Economic Outlook
00:10:00
European Commercial Real Estate Sector Adapts to Economic Shifts and Embraces Logistics Amidst Higher Interest Rates | Simon Garing, CEO, Cromwell European Real Estate Investment Trust.
00:10:00
The Legacy of Barry Humphries: A Comedic Icon's Impact|Andrew Gleeson,Professor,Harvard University

© 2017 - Neuhu+